XTX Topco’s Arcadia Biosciences RKDA Stock Holding History

XTX Topco’s Portfolio RKDA Stock Details RKDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-310	Closed	-$17K	–	1069
2022 Q1	$17K	Buy	+310	New	+$14.8K	0.01%	632

Other funds holding RKDA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

MYDA Advisors Woodmere, New York $608M AUM 77.08% 1-Year Est. Return

XTX Topco's RKDA Position: Q2 2022 in Review

XTX Topco sold out of Arcadia Biosciences (RKDA) in Q2 2022, closing a stake of 310 shares — an estimated $17K sold.

XTX Topco first reported a position in RKDA in Q1 2022 and held it in 1 quarter. The position peaked at $17K in Q1 2022. 22 funds tracked by Wall St. Rank hold RKDA as of Q2 2022.

XTX Topco reported no remaining Arcadia Biosciences position as of Q2 2022 after selling out during the quarter.
XTX Topco sold 310 Arcadia Biosciences shares in Q2 2022, an estimated $17K.
XTX Topco first reported a position in Arcadia Biosciences in Q1 2022 and held it in 1 quarter.
XTX Topco's Arcadia Biosciences position peaked at $17K in Q1 2022.
22 funds tracked by Wall St. Rank held Arcadia Biosciences as of Q2 2022.

Based on XTX Topco's 13F filing for Q2 2022, filed 15 Aug 2022.